Title : Systemic therapy for hepatocellular carcinoma: beyond sorafenib.

Pub. Date : 2018 Oct

PMID : 30395717






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In 2007, sorafenib became the first Food and Drug Administration (FDA) approved first line systemic treatment for HCC, however, it confers only modest benefit in median overall survival (mOS) and comes with significant side effects. Sorafenib Moloney sarcoma oncogene Mus musculus